AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40

Authors: Ghani, AC de Wolf, F Ferguson, NM Donnelly, CA Coutinho, R Miedema, F Goudsmit, J Anderson, RM
Citation: Ac. Ghani et al., Surrogate markers for disease progression in treated HIV infection, J ACQ IMM D, 28(3), 2001, pp. 226-231

Authors: Messele, T Brouwer, M Girma, M Fontanet, AL Miedema, F Hamann, D de Wit, TFR
Citation: T. Messele et al., Plasma levels of viro-immunological markers in HIV-infected and noninfected ethiopians: Correlation with cell surface activation markers, CLIN IMMUNO, 98(2), 2001, pp. 212-219

Authors: Foudraine, NA Jurriaans, S Weverling, GJ Burger, DM Hoetelmans, RMW Roos, MTL Maas, J Miedema, F Reiss, P Portegies, P de Wolf, F Lange, JMA
Citation: Na. Foudraine et al., Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial, ANTIVIR TH, 6(1), 2001, pp. 55-62

Authors: Hazenberg, MD Verschuren, MCM Hamann, D Miedema, F van Dongen, JJM
Citation: Md. Hazenberg et al., T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation, J MOL MED-J, 79(11), 2001, pp. 631-640

Authors: Van Praag, RME Prins, JM Roos, MTL Schellekens, PTA Ten Berge, IJM Yong, SL Schuitemaker, H Eerenberg, AJM Jurriaans, S De Wolf, F Fox, CH Goudsmit, J Miedema, F Lange, JMA
Citation: Rme. Van Praag et al., OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion, J CLIN IMM, 21(3), 2001, pp. 218-226

Authors: Kostense, S Raaphorst, FM Joling, J Notermans, DW Prins, JM Danner, SA Reiss, P Lange, JMA Teale, JM Miedema, F
Citation: S. Kostense et al., T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy, AIDS, 15(9), 2001, pp. 1097-1107

Authors: Lindenburg, CEA Langendam, MW Von Benthem, BHB Miedema, F Coutinho, RA
Citation: Cea. Lindenburg et al., No evidence that vaccination with a polysaccharide pneumococcal vaccine protects drug users against all-cause pneumonia, AIDS, 15(10), 2001, pp. 1315-1317

Authors: Petit, MDA Hovenkamp, E Hamann, D Roos, MTL van der Velden, U Miedema, F Loos, BG
Citation: Mda. Petit et al., Phenotypical and functional analysis of T cells in periodontitis, J PERIOD RE, 36(4), 2001, pp. 214-220

Authors: Kostense, S Ogg, GS Manting, EH Gillespie, G Joling, J Vandenberghe, K Veenhof, EZ van Baarle, D Jurriaans, S Klein, MR Miedema, F
Citation: S. Kostense et al., High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function, EUR J IMMUN, 31(3), 2001, pp. 677-686

Authors: van Baarle, D Hovenkamp, E Callan, MFC Wolthers, KC Kostense, S Tan, LC Niesters, HGM Osterhaus, ADME McMichael, AJ van Oers, MHJ Miedema, F
Citation: D. Van Baarle et al., Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-relatednon-Hodgkin lymphoma, BLOOD, 98(1), 2001, pp. 146-155

Authors: Hazenberg, MD Hamann, D Schuitemaker, H Miedema, F
Citation: Md. Hazenberg et al., T cell depletion in HIV-I infection: how CD4(+) T cells go out of stock, NAT IMMUNOL, 1(4), 2000, pp. 285-289

Authors: Stuart, JWTC Hazebergh, MD Hamann, D Otto, SA Borleffs, JCC Miedema, F Boucher, CAB de Boer, RJ
Citation: Jwtc. Stuart et al., The dominant source of CD4(+) and CD8(+) T-cell activation in HIV infection is antigenic stimulation, J ACQ IMM D, 25(3), 2000, pp. 203-211

Authors: Hazenberg, MD Otto, SA Stuart, JWTC Verschuren, MCM Borleffs, JCC Boucher, CAB Coutinho, RA Lange, JMA De Wit, TFR Tsegaye, A Van Dongen, JJM Hamann, D De Boer, RJ Miedema, F
Citation: Md. Hazenberg et al., Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection, NAT MED, 6(9), 2000, pp. 1036-1042

Authors: Messele, T Roos, MTL Hamann, D Koot, M Fontanet, AL Miedema, F Schellekens, PTA de Vit, TFR
Citation: T. Messele et al., Nonradioactive techniques for measurement of in vitro T-cell proliferation: Alternatives to the [H-3]thymidine incorporation assay, CL DIAG LAB, 7(4), 2000, pp. 687-692

Authors: Kostense, S Krop, E Blaak, H Schuitemaker, H Miedema, F
Citation: S. Kostense et al., Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants, AIDS, 14(3), 2000, pp. 330-331

Authors: Lindenburg, K Langendam, MW Veenstra, J Miedema, F Coutinho, R
Citation: K. Lindenburg et al., Long-term effects of therapeutic vaccination with rgp 120, AIDS, 14(2), 2000, pp. 203-204

Authors: Fleury, S Rizzardi, GP Chapuis, A Tambussi, G Knabenhans, C Simeoni, E Meuwly, JY Corpataux, JM Lazzarin, A Miedema, F Pantaleo, G
Citation: S. Fleury et al., Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy, P NAS US, 97(10), 2000, pp. 5393-5398

Authors: Roos, MTL van Lier, RAW Hamann, D Knol, GJ Verhoofstad, I van Baarle, D Miedema, F Schellekens, PTA
Citation: Mtl. Roos et al., Changes in the composition of circulating CD8(+) T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans, J INFEC DIS, 182(2), 2000, pp. 451-458

Authors: van Baarle, D Hovenkamp, E Dukers, NHTM Renwick, N Kersten, MJ Goudsmit, J Coutinho, RA Miedema, F van Oers, MHJ
Citation: D. Van Baarle et al., High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission, J INFEC DIS, 181(6), 2000, pp. 2045-2049

Authors: Clark, DR Repping, S Pakker, NG Prins, JM Notermans, DW Wit, FWNM Reiss, P Danner, SA Coutinho, RA Lange, JMA Miedema, F
Citation: Dr. Clark et al., T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy, BLOOD, 96(1), 2000, pp. 242-249

Authors: Hazenberg, MD Stuart, JWTC Otto, SA Borleffs, JCC Boucher, CAB de Boer, RJ Miedema, F Hamann, D
Citation: Md. Hazenberg et al., T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART), BLOOD, 95(1), 2000, pp. 249-255

Authors: Hamann, D Kostense, S Wolthers, KC Otto, SA Baars, PA Miedema, F van Lier, RAW
Citation: D. Hamann et al., Evidence that human CD8(+)CD45RA(+)CD27(-) cells are induced by antigen and evolve through extensive rounds of division, INT IMMUNOL, 11(7), 1999, pp. 1027-1033

Authors: Wolthers, KC Noest, AJ Otto, SA Miedema, F De Boer, RJ
Citation: Kc. Wolthers et al., Normal telomere lengths in naive and memory CD4(+) T cells in HIV type 1 infection: A mathematical interpretation, AIDS RES H, 15(12), 1999, pp. 1053-1062

Authors: Pontesilli, O Carotenuto, P Kerkhof-Garde, SR Roos, MTM Keet, IPM Coutinho, RA Goudsmit, J Miedema, F
Citation: O. Pontesilli et al., Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type I infection is predictive of persistent AIDS-free infection, AIDS RES H, 15(11), 1999, pp. 973-981

Authors: Krol, A Flynn, C Vlahov, D Miedema, F Coutinho, RA van Ameijden, EJC
Citation: A. Krol et al., New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users, DRUG AL DEP, 54(2), 1999, pp. 145-154
Risultati: 1-25 | 26-40